Toronto, Ontario (Newsfile Corp. - February 22, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is excited to announce the launch of our inaugural multiple myeloma clinical
Telo Genomics Forms World-Class Multiple Myeloma Advisory Board in Preparation for the American Society of Hematology Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Toronto, Ontario (Newsfile Corp. - December 8, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is pleased to announce the formation of a multiple myeloma advisory board
Researchers found less of an immune system response to the COVID-19 vaccines in patients with cancer who are on chemotherapy. A third shot helped, though.
Cancer Patients on Chemotherapy Likely Not Fully Protected by COVID-19 Vaccine arizona.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arizona.edu Daily Mail and Mail on Sunday newspapers.